H. D. White

2.5k total citations
46 papers, 1.8k citations indexed

About

H. D. White is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, H. D. White has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in H. D. White's work include Acute Myocardial Infarction Research (24 papers), Cardiac Imaging and Diagnostics (11 papers) and Atrial Fibrillation Management and Outcomes (10 papers). H. D. White is often cited by papers focused on Acute Myocardial Infarction Research (24 papers), Cardiac Imaging and Diagnostics (11 papers) and Atrial Fibrillation Management and Outcomes (10 papers). H. D. White collaborates with scholars based in New Zealand, United States and United Kingdom. H. D. White's co-authors include D. Cross, R M Norris, Pierre Théroux, Gabriel I. Barbash, G Tognoni, N Danchin, Andreas Jessel, Bernard Chaitman, Leif Erhardt and J. T. Willerson and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

H. D. White

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. D. White New Zealand 21 1.4k 503 454 186 170 46 1.8k
Pierre Théroux Canada 19 1.5k 1.1× 625 1.2× 514 1.1× 71 0.4× 117 0.7× 37 2.0k
M. L. Simoons Netherlands 17 1.1k 0.8× 430 0.9× 292 0.6× 97 0.5× 91 0.5× 44 1.4k
Lars Grip Sweden 22 927 0.7× 771 1.5× 247 0.5× 151 0.8× 288 1.7× 72 1.8k
De Backer G United Kingdom 3 1.6k 1.2× 711 1.4× 458 1.0× 69 0.4× 85 0.5× 12 2.2k
Gabriel B. Habib United States 17 1.2k 0.9× 541 1.1× 570 1.3× 71 0.4× 200 1.2× 36 1.8k
Ernesto Paolasso Argentina 17 1.5k 1.1× 469 0.9× 274 0.6× 118 0.6× 115 0.7× 19 2.0k
Jacek S. Dubiel Poland 23 1.7k 1.2× 673 1.3× 480 1.1× 45 0.2× 123 0.7× 155 2.2k
Russell J. Ivanhoe United States 12 2.5k 1.8× 1.4k 2.7× 623 1.4× 96 0.5× 386 2.3× 19 3.3k
Alon Eisen Israel 19 816 0.6× 344 0.7× 242 0.5× 110 0.6× 116 0.7× 96 1.2k
Sasha Koul Sweden 27 1.3k 0.9× 507 1.0× 503 1.1× 216 1.2× 79 0.5× 117 2.0k

Countries citing papers authored by H. D. White

Since Specialization
Citations

This map shows the geographic impact of H. D. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. D. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. D. White more than expected).

Fields of papers citing papers by H. D. White

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. D. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. D. White. The network helps show where H. D. White may publish in the future.

Co-authorship network of co-authors of H. D. White

This figure shows the co-authorship network connecting the top 25 collaborators of H. D. White. A scholar is included among the top collaborators of H. D. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. D. White. H. D. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nilsson, Kent R., Sana M. Al‐Khatib, Yi Zhou, et al.. (2010). Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart. 96(11). 838–842. 24 indexed citations
2.
Tjandrawidjaja, Michael C., Ya–Yuan Fu, Cynthia M. Westerhout, et al.. (2009). Resolution of ST-segment depression: a new prognostic marker in ST-segment elevation myocardial infarction. European Heart Journal. 31(5). 573–581. 23 indexed citations
3.
Lópes, Renato D., Gretchen Marcucci, H. D. White, et al.. (2008). Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial. European Heart Journal. 29(15). 1827–1833. 34 indexed citations
4.
Alpert, J. S., Kristian Thygesen, A S Jaffe, & H. D. White. (2008). The universal definition of myocardial infarction: a consensus document. Heart. 94(10). 1335–1341. 81 indexed citations
5.
Mark, Daniel B., Frans Van de Werf, R. John Simes, et al.. (2007). Cardiovascular disease on a global scale: defining the path forward for research and practice. European Heart Journal. 28(21). 2678–2684. 25 indexed citations
6.
Marschner, Ian C., David Colquhoun, R. J. Simes, et al.. (2001). Long-term risk stratification for survivors of acute coronary syndromes. Journal of the American College of Cardiology. 38(1). 56–63. 104 indexed citations
7.
French, John K. & H. D. White. (1999). Direct thrombin inhibitors as adjuncts to thrombolytic therapy. Current Cardiology Reports. 1(3). 184–191. 1 indexed citations
8.
French, John K., Barbara F. Williams, D. Cross, et al.. (1999). Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow. Journal of the American College of Cardiology. 33(1). 139–145. 20 indexed citations
9.
White, H. D.. (1998). Direct thrombin inhibition and thrombolytic therapy: rationale for the hirulog and early reperfusion/occlusion (HERO-2) trial. The American Journal of Cardiology. 82(8). 57P–62P. 18 indexed citations
10.
Califf, Robert M., Lynn H. Woodlief, Frank E. Harrell, et al.. (1997). Selection of thrombolytic therapy for individual patients: Development of a clinical model. American Heart Journal. 133(6). 630–639. 61 indexed citations
11.
White, H. D.. (1997). Is Heparin of Value in the Management of Acute Myocardial Infarction?. Cardiovascular Drugs and Therapy. 11(2). 111–119. 7 indexed citations
12.
Norris, R M, H. D. White, H. Hart, & B F Williams. (1996). Comparison of aspirin with a thromboxane antagonist for patients with prolonged chest pain and ST segment depression.. PubMed. 109(1026). 278–80. 3 indexed citations
13.
French, J., B F Williams, H. Hart, et al.. (1996). Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ. 312(7047). 1637–1641. 78 indexed citations
14.
Barbash, Gabriel I., Jonathan Reiner, H. D. White, et al.. (1995). Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the “smoker's paradox” from the GUSTO-I trial, with angiographic insights. Journal of the American College of Cardiology. 26(5). 1222–1229. 198 indexed citations
15.
16.
White, H. D.. (1992). Remodelling of the heart after myocardial infarction. Australian and New Zealand Journal of Medicine. 22(5). 601–606. 6 indexed citations
17.
Norris, R M, H. D. White, D. Cross, C. Wild, & R. M. L. Whitlock. (1992). Prognosis after recovery from myocardial infarction: the relative importance of cardiac dilatation and coronary stenoses. European Heart Journal. 13(12). 1611–1618. 25 indexed citations
18.
19.
Rivers, John T., H. D. White, D. Cross, Barbara F. Williams, & R M Norris. (1990). Reinfarction after thrombölytic therapy for acute myocardial infarction followed by conservative management: Incidence and effect of smoking. Journal of the American College of Cardiology. 16(2). 340–348. 66 indexed citations
20.
White, H. D.. (1990). GISSI-2 and the heparin controversy. The Lancet. 336(8710). 297–298. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Théroux Breakdown of academic impact, for papers by M. L. Simoons Breakdown of academic impact, for papers by Lars Grip Breakdown of academic impact, for papers by De Backer G Breakdown of academic impact, for papers by Gabriel B. Habib Breakdown of academic impact, for papers by Ernesto Paolasso Breakdown of academic impact, for papers by Jacek S. Dubiel Breakdown of academic impact, for papers by Russell J. Ivanhoe Breakdown of academic impact, for papers by Alon Eisen Breakdown of academic impact, for papers by Sasha Koul
Rankless by CCL
2026